PRESS RELEASE published on 07/18/2024 at 08:00, 1 year 9 months ago Lucibel à bord de l'IMOCA MACIF Santé Prévoyance de Charlie Dalin, récent vainqueur de la New York Vendée LUCIBEL collabore avec le skipper Charlie Dalin pour développer un dispositif lumineux innovant sur l'IMOCA MACIF Santé Prévoyance, améliorant sa performance en mer Collaboration Lucibel Charlie Dalin IMOCA MACIF Santé Prévoyance Luminaire Sur-mesure
PRESS RELEASE published on 07/18/2024 at 07:30, 1 year 9 months ago AUTO1 Group successfully prices debut public market German consumer car loan ABS AUTO1 Group successfully prices debut public market German consumer car loan ABS, raising EUR 223 million for Autohero segment with AAA rated notes and 87bps spread AUTO1 Group Financial Transaction Autohero Securitisation German Consumer Car Loan ABS
REGULATED PRESS RELEASE published on 07/18/2024 at 07:30, 1 year 9 months ago OPmobility équipera les premiers trains hydrogène de Stadler en Europe OPmobility remporte un contrat majeur pour équiper des trains hydrogène de Stadler en Europe, renforçant sa position de leader mondial de la mobilité hydrogène Transition Énergétique OPmobility Stadler Trains Hydrogène Mobilité Ferroviaire
REGULATED PRESS RELEASE published on 07/18/2024 at 07:30, 1 year 9 months ago OPmobility to equip Stadler's first hydrogen trains in Europe OPmobility to equip Stadler's first hydrogen trains in Europe with high-pressure hydrogen storage and fuel cell systems, marking a significant step in decarbonizing rail mobility Decarbonization OPmobility Stadler Hydrogen Trains Rail Mobility
PRESS RELEASE published on 07/18/2024 at 07:30, 1 year 9 months ago Informations privilégiées / Communiqué sur comptes, résultats
PRESS RELEASE published on 07/18/2024 at 07:30, 1 year 9 months ago Nicox Provides Second Quarter 2024 Update Nicox reports €1.6M revenue & €7.8M cash for Q2 2024, extending funds until Feb 2025. Focus on NCX 470 development & Denali trial progress. New Board members appointed Revenue Cash Position Nicox NCX 470 Denali Trial
PRESS RELEASE published on 07/18/2024 at 07:30, 1 year 9 months ago Informations privilégiées / Autres communiqués Maurel & Prom annonce une production en hausse de 29% au premier semestre 2024, valorisation de 310 M$ et trésorerie nette positive de 27 M$. Dividende de 0,30€ par action. Chiffre d'affaires consolidé de 412 M$ Chiffre D'affaires Dividende Trésorerie Nette Valorisation Production Maurel & Prom
PRESS RELEASE published on 07/18/2024 at 07:30, 1 year 9 months ago Crossject achieves key ZEPIZURE® manufacturing milestone Crossject achieves key ZEPIZURE manufacturing milestone with successful completion of new registration batch at Eurofins' qualified facility, supporting EUA timelines Emergency Use Authorization Crossject ZEPIZURE Eurofins Manufacturing Milestone
PRESS RELEASE published on 07/18/2024 at 07:30, 1 year 9 months ago Viridien Announces its Q2 Financial Results on Tuesday 30th July 2024, after Market Close Viridien (formerly CGG) to announce Q2 2024 financial results on July 30th, 2024, after market close. Details and analysts conference call information available on www.viridiengroup.com Euronext Paris Technology Company Q2 Financial Results Viridien Analysts Conference Call
PRESS RELEASE published on 07/18/2024 at 06:45, 1 year 9 months ago Solid demand; record-high Operational EBITA margin ABB Ltd reports solid demand in Q2 2024 with record-high Operational EBITA margin of 19%. Orders at $8,435 million, revenues at $8,239 million. CEO Björn Rosengren pleased with results Financial Results ABB Ltd Operational EBITA Q2 2024 Record-high
Published on 05/09/2026 at 00:00, 1 day 1 hour ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 6 hours 40 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 5 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 6 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 6 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 6 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 6 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 6 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 6 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 6 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
